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NAME OF ORGANIZATION 
Georgia Institute of Technology 	 July 1, 1980 	June 30, 1981 
TITLE (Repeat title shown in Item 1 on first page) 
Fatty Acyl CoA Dehydrogenase and ETF 
1. List publications: (a) published and not previously reported; (b) in press. Provide five reprints if not previously submitted. 
2. List all additions and deletions in professional personnel and any changes in effort. 
3. Progress Report. (See Instructions) 
1(b) 1.Carole L. Hall, Federation Proceeding 1980:'Dehydrogenation of Acyl CoA 
Dehydrogenase (GAD) and ETFAin press). 
2.Carole L. Hall, 14th Annual Regional Lipid Conference, Knoxville, Tenn.(1979) 
"A New Specific Assay for ETF and ETF-linked acyl CoA Dehydrogenases." 
3.Carole L. Hall and J. David Lambeth, J. Biol. Chem., "Electron Transfer from 
Fatty Ac CoA to General Acyl CoA Dehydrogenase and Electron Transfer Flavo-
protein," in press., due April 25,1980 
4.Carole L. Hall, Methods in Enzymology, Lipids (J.M. Lowenstein Ed.) "Acyl CoA 
Dehydrogenases from Pig Liver Mitochondria (in press) 
5.Carole L. Hall, Methods in Enzymology, Lipids (J. M. Lowenstein, Ed. (in press). 
"ETF from Pig Liver Mitochondria" (in press). 
(c) 1.Carole L. Hall, submitted to J. Biol. Chem., "On the Dehydrogenation of Acyl 
CoA by General Acyl CoA Dehydrogenase and Electron Transfer Flavoprotein". 
2.Carole L. Hall, M.S. in preparation "Isovaleryl CoA Dehydrogenase, A New 
Electron Transfer Flavoprotein-linked Flavoenzyme." 
3.Carole L. Hall, "Assay of Electron Transfer Flavoprotein and ETF Linked Dehydro-
genasesby Fluorescence Measurements." (M.S. in Preparation). 
2. Professional Personnel 
Changes: Teresa M. DeTar left voluntarily. 
Eric N. Juberg was hired to fill the position vacated by T. M. DeTar. 
Changes in Effort: Carole L. Hall taught at Georgia Tech during 1979-1980 and 
effort was reduced to 95%. Compensation was provided by Georgia Tech. 
3. The long term goal is to elucidate the interaction of the two flavoproteins 
required in ct,3-dehydrogenation of fatty acyl CoA's in xidation with each other, 
with the substrate and products of the dehydrogenation and with the rest of the 
3--oxidation enzymes, and to determine the mechanisms of the electron transfers 
involved and fate of product. This is being approached by rapid reaction and 
anaerobic titration techniques (utilizing the characteristic absorbance and 
fluorescences of those enzymes) displacement studies, and studies of catalytic 
activity in dye-complexed systems. 
The aims of the research are: 
(a) to determine if 2 4 to 1 6 transduction occurs on the dehydrogenase, 
between the two flavoproteins, on the ETF or at some other site (e.g., interaction 
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with the electron transport chain. 
(b) To probe the relationship between these flavoproteins and the rest 
of the R-oxidation enzymes as possible effectors of the dehydrogenation. 
(c) To determine the redox properties of the two flavoproteins both 
separately and together. 
(d) To probe the nature of the apparent oxidized acyl CoA complex 
(green) of the short chain enzyme by attempting to displace and replace the 
complexing agent and to probe the postulated effects of hypoglycemic agents. 
(e) To identify additional flavoproteins which have been isolated and 
interact with acyl CoA derivatives. 
I have continued to investigate absorbance changes during catalysis to try to 
ascertain the mechanism of electron flow through this system. Some of the 
results are summarized in the following abstract accepted for presentation at 
the June 1980 ASBC/BS meeting in New Orleans, La. 
DEHYDROGENATION OF ACYL CoA BY GENERAL ACYL CoA DEHYDROGENASE 
(G-AD) AND ETF. C. L. Hall* (SPON: D. H. Hall). School of 
Chemistry, Georgia Tech, Atlanta, Ga. 30332 
Medium chain acyl CoA's bind rapidly and tightly to G-AD 
and rapidly (100 sec -1) bleach the flavin. G-AD-C CoA complex 
i 
reduces ETF first to anionic semiquinone ( 6 x 10 68M-1 sec-1 ) 
and then to the fully reduced form ( 5 x 10 5 M-1 sec-1). Sub- 
strate-reduced ETF is reoxidized only slowly by air. Spectra 
of ETF observed during turnover with catalytic amounts of G-AD 
and 4-fold molar excesses of C,,tCoA per ETF flavin showed chan- 
ges in the UV and near UV whict could be correlated with visi-
ble absorbance changes known to reflect redox states of ETF 
flavin. All of the ETF was converted to the anionic semiqui-
none (increase at 380 nm) and fully reduced (decrease at 380 
nm) forms with rate constants virtually identical to those 
seen previously. Absorption at 320 nm increased with a rate 
constant similar to that for formation of fully reduced ETF, 
and decreased only as the flavin absorption at 440 nm returned. 
Increased absorbance at 280 nm ( expected to indicate free 
enoyl CoA) appeared only as the 320 nm absorbance decreased. 
Changes at 280 nm showed that all of the substrate was dehydro- 
genated. The data suggest that G-AD-C 0CoA complex interacts 
with ETF to transfer one electron to tNe ETF flavin and then 
a new complex (represented by A 320 ) is formed more slowly with 
transfer of the second electron. This complex can not include 
G-AD but seems to involve reduced ETF and acyl CoA since the 
enoyl CoA is not released until the ETF is reoxidized. 
(Supported by USPHS grant #GM 25494). 
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I have also purified and characterized a new ETF-linked flavoprotein which 
dehydrogenates isovaleryl CoA, a function previously thought to be carried 
out by general (G-AD) or short chain (SC-AD) acyl CoA dehydrogenases. In- 
stead these highly purified enzymes do not utilize catalytically or form spec-
trally identifiable complexes with this branched-chain acyl CoA derived from 
amino acid catabolism. A manuscript describing the properties of this enzyme 
is in preparation and expected to be ready for submission shortly. 
Other experiments involving this enzyme were and are still being carried out 
in collaboration with Dr. William Rhead of The University of Iowa Medical 
Center, Ames, Iowa. A manuscript describing the wirk is in preparation. 
In addition, Dr. Stephen Goodman of the University of Colorado Medical 
School, Denver, Colorado has initiated collaborative efforts to try to 
detect ETF in liver of human victims of as yet uncharacterized organic 
acidemias and acidurias. I have recently developed new specific, quanti-
tative and fairly sensitive methods of measuring ETF fluoriometrically in 
crude samples. A preliminary report of these methods was made in Sept. 
1979 at the Regional Lipids Conference in Nashville, Tenn. A manuscript 
describing the results is in preparation. 
A series of experiments probing the mechanism of phenazine methosulfate 
action as an electron acceptor for acyl CoA dehydrogenase has begun, using 
both absorption and EPR Spectroscopy (in collaboration with a student, Mr. 
Mitchell Gould and Drs. B. Yamanashi and S. Lerman of the Department of 
Opthamology, Emory University Medical Center. Preliminary experiments prob-
ing the usefulness of pyocyanine (reduced by lipoyldehydrogenase and NaDH) 
as a reductant for ETF were positive. This is the first instance of ETF 
being reduced by anything other than reduced acyl CoA dehydrogenase. The 
use of these dye systems will potentially permit redox measurements of the 
acyl CoA dehydrogenase-substrate complex and of the ETF. 
Finally, preliminary experiments to try to probe the nature of the acyl CoA 
dehydrogenase-substrate complex by EPR have begun,again in collaboration with 
Mr. Gould and Drs. Yamanashi and Lerman. 
The research goals for the coming year are: 
a) To study the formation and breakdown of the putative reduced 
ETF-enoyl CoA complex using different chain length (and branched chain) sub-
strates and different dehydrogenases (short chain, isovaleryl). 
b) To test the utility of the fluorescence assay for ETF using rat liver 
and human autopsy liver mitochondria, as well as other tissues as available. 
c) To probe electron flow between acyl CoA dehydrogenase and ETF 
with emphasis on redox potentials and stoichiometry. 
d) To continue to probe the acyl CoA dehydrogenase substrate complex 
using PMS and EPR spectroscopy 
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e) To continue in attempts to displace and identify the "greening" 
ligand of short chain acyl CoA dehydrogenase and to synthesiz possible 
ligands. 
f) To further study the putative " 13-oxidase complex" of pig liver 
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